Analysts have varying views on the stock, with 1 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 as “hold,” and 0 as “sell.”
The average price suggested by analysts for VRPX is $4.00, which is $2.92 above the current market price. The public float for VRPX is 8.70M, and currently, shorts hold a 0.89% of that float. The average trading volume for VRPX on June 20, 2023 was 19.33K shares.
Top 5 AI Stocks to Buy for 2023
The artificial intelligence (AI) revolution is already here. And it’s about to change everything we know about everything.
According to Grand View Research, the global AI boom could grow from about $137 billion in 2022 to more than $1.81 trillion by 2030. And investors like you always want to get in on the hottest stocks of tomorrow. Here are five of the best ways to profit from the AI boom.
Click Here to Download the FREE Report.
Sponsored
VRPX) stock’s latest price update
Virpax Pharmaceuticals Inc. (NASDAQ: VRPX) has experienced a rise in its stock price by 17.39 compared to its previous closing price of 0.92. However, the company has seen a gain of 19.50% in its stock price over the last five trading days.
VRPX’s Market Performance
Virpax Pharmaceuticals Inc. (VRPX) has experienced a 19.50% rise in stock performance for the past week, with a 30.91% rise in the past month, and a 22.73% rise in the past quarter. The volatility ratio for the week is 9.24%, and the volatility levels for the past 30 days are at 9.59% for VRPX. The simple moving average for the past 20 days is 27.58% for VRPX’s stock, with a 18.64% simple moving average for the past 200 days.
VRPX Trading at 37.16% from the 50-Day Moving Average
After a stumble in the market that brought VRPX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -40.98% of loss for the given period.
Volatility was left at 9.59%, however, over the last 30 days, the volatility rate increased by 9.24%, as shares surge +30.12% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +36.73% upper at present.
During the last 5 trading sessions, VRPX rose by +19.50%, which changed the moving average for the period of 200-days by -16.92% in comparison to the 20-day moving average, which settled at $0.8591. In addition, Virpax Pharmaceuticals Inc. saw 73.55% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for VRPX
Equity return is now at value -92.30, with -79.10 for asset returns.
The liquidity ratio also appears to be rather interesting for investors as it stands at 6.36.
Conclusion
In conclusion, Virpax Pharmaceuticals Inc. (VRPX) has had a better performance lately. Opinion on the stock among analysts is bullish, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.